Possible Value of Antifibrotic Drugs in Patients with Progressive Fibrosing Non-IPF Interstitial Lung Diseases

被引：0
|
作者：
Torrisi, S. [1 ,2 ,3 ]
Kahn, N. C. [1 ,2 ,3 ]
Waelscher, J. [1 ,2 ,3 ]
Sarmand, N. [1 ,2 ,3 ]
Polke, M. [1 ,2 ,3 ]
Heussel, C. [2 ,3 ,4 ]
Palmucci, S. [5 ]
Sambataro, G. [6 ]
Vancheri, C. [6 ]
Kreuter, M. [1 ,2 ,3 ]
机构：
[1] Heidelberg Univ, Ctr Interstitial & Rare Lung Dis, Thoraxklin, Heidelberg, Germany
[2] Translat Lung Res Ctr Heidelberg, Heidelberg, Germany
[3] German Ctr Lung Res, Heidelberg, Germany
[4] Heidelberg Univ, Thoraxklin, Radiol, Heidelberg, Germany
[5] Univ Hosp, Dept Med Surg Sci & Adv Technol, Radiol Unit 1, Catania, Italy
[6] Univ Catania, Dept Clin & Expt Med, Reg Referral Ctr Rare Lung Dis, AOU Policlin Vittorio Emanuele, Catania, Italy
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4765
引用
收藏
页数：2
相关论文
共 50 条
  • [31] BEYOND CLINICALTRIALS: EFFICACY AND SAFETY OF NINTEDANIB IN IPF AND PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES IN CLINICAL PRACTICE
    De Gracia, A. I.
    Bea, C.
    Fuertes, E.
    De Castro, A.
    Navarro, L.
    Prades, C.
    Ruiz, D.
    Albiol, P.
    Forner, M. J.
    Vela-Bernal, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1662 - 1663
  • [32] The natural history of progressive fibrosing interstitial lung diseases
    Kolb, Martin
    Vasakova, Martina
    RESPIRATORY RESEARCH, 2019, 20 (1)
  • [33] Progressive Fibrosing Interstitial Lung Diseases: A Current Perspective
    Albera, Carlo
    Verri, Giulia
    Sciarrone, Federico
    Sitia, Elena
    Mangiapia, Mauro
    Solidoro, Paolo
    BIOMEDICINES, 2021, 9 (09)
  • [34] The natural history of progressive fibrosing interstitial lung diseases
    Martin Kolb
    Martina Vašáková
    Respiratory Research, 20
  • [35] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases Reply
    Flaherty, Kevin R.
    Wells, Athol U.
    Brown, Kevin K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08): : 781 - 781
  • [36] The natural history of progressive fibrosing interstitial lung diseases
    Brown, Kevin K.
    Martinez, Fernando J.
    Walsh, Simon L. F.
    Thannickal, Victor J.
    Prasse, Antje
    Schlenker-Herceg, Rozsa
    Goeldner, Rainer-Georg
    Clerisme-Beaty, Emmanuelle
    Tetzlaff, Kay
    Cottin, Vincent
    Wells, Athol U.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (06)
  • [37] Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases
    Chen, Xianqiu
    Guo, Jian
    Yu, Dong
    Jie, Bing
    Zhou, Ying
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [38] The Burden of Progressive-Fibrosing Interstitial Lung Diseases
    Cottin, Vincent
    Teague, Rhiannon
    Nicholson, Lindsay
    Langham, Sue
    Baldwin, Mike
    FRONTIERS IN MEDICINE, 2022, 9
  • [39] Nintedanib for treating progressive fibrosing interstitial lung diseases
    Adler, Amanda, I
    Guo, Yelan
    Thiam, Aminata
    Elliott, Nicole
    Patel, Sanjeev
    LANCET RESPIRATORY MEDICINE, 2021, 9 (12): : E116 - E117
  • [40] Analyzing the variance in protein expression profiles between patients diagnosed with idiopathic pulmonary fibrosis (IPF) and those with non-IPF interstitial lung diseases (ILD)
    Yen, Tsai-Hung
    Fu, Pin-Kuei
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
12345